What's New
News
A Week of Awareness…
Grassroots volunteers and FTD experts from around the globe joined AFTD to mark World FTD Awareness Week…
AFTD to Host Patient-Focused Drug Development Meeting with FDA
In March, people and families affected by FTD will have the opportunity to speak directly to representatives…
Wash. Post Reports on FTD and Other Atypical Dementias
People in their 50s and 60s are increasingly being diagnosed with non-Alzheimer’s forms of dementia, including frontotemporal…
Watch the 2020 World FTD Marathon…
The first-ever World FTD Marathon, a day-long series of interactive webinars from around the globe, is now…
Building a Future Free of FTD: AFTD’s 2020 Annual Report
AFTD’s 2020 Annual Report documents progress made in the fiscal year commencing July 1, 2019 and ending…
When the Conversation Stops: Logopenic Variant Primary Progressive Aphasia
Partners in FTD Care, Fall 2020 Download the full issue (pdf) Primary progressive aphasia (PPA) is a neurodegenerative…
AFTD-Backed Research Offers Insights into C9orf72 Protein Structure
New AFTD-funded research published in Nature provides important insights into the structure of the C9orf72 protein, which…
AFTD Volunteer Talks #FTDhotshotchallenge in Canadian Newspaper
AFTD volunteer Amanda Dawson explains how the #FTDhotshotchallenge is helping to raise awareness of FTD — and…
AFTD Seeking Community Input Ahead of Patient-Focused Drug Development Meeting
On March 5, 2021, AFTD will host a Patient-Focused Drug Development meeting with representatives of the U.S….
Washington Post Details Impacts of COVID Isolation on Families Facing Dementia
As families facing FTD continue to also contend with the challenges of navigating the COVID-19 pandemic, the Washington…
English 
Spanish (Mexico) 
French 
German 
Swedish 
Portuguese 
Italian 
Dutch 
Danish 
Polish 
Spanish (Spain)